[논문]HPLC-DAD stability indicating determination of nizatidine in bulk and capsules dosage form

Belal, T.S.; Abdel-Hay, M.H.; Sabry, S.M.; Mahgoub, A.A.

doi:10.1016/j.bfopcu.2013.05.001

HPLC-DAD stability indicating determination of nizatidine in bulk and capsules dosage form 원문보기

Bulletin of Faculty of Pharmacy, Cairo University, v.51 no.2, 2013년, pp.185 - 191

Belal, T.S. , Abdel-Hay, M.H. , Sabry, S.M. , Mahgoub, A.A.

Abstract ▼ AI-Helper

This work describes the stability-indicating determination of the H2-receptor antagonist nizatidine in its bulk and capsules dosage form using high performance liquid chromatography coupled with diode array detector (HPLC-DAD). The developed method involved the use of Thermo Hypersil BDS-C8 (4.6x250mm, 5μm particle size) column and a mobile phase composed of 0.05M phosphoric acid and acetonitrile (50:50, v/v). The mobile phase was pumped at a flow rate of 1mL/min. Quantification of nizatidine was based on measuring its peak area at 320nm. The retention time for nizatidine was about 3.61min. The reliability and analytical performance of the proposed HPLC procedure were statistically validated with respect to linearity, range, precision, accuracy, specificity, robustness, detection and quantification limits. Calibration curve of nizatidine was linear in the range of 5-50μg/mL with correlation coefficient >0.9999. The drug was subjected to forced-degradation conditions of acidic and basic hydrolysis, oxidation, dry heat and UV photolysis where it showed considerable degradation in basic and oxidative conditions. The proposed method proved to be specific and stability-indicating by resolution of the drug from its forced-degradation products. The validated HPLC method was applied to the analysis of nizatidine in capsules dosage form where it was quantified with recoveries not less than 98.2%. Assay results were statistically compared to USP 2011 pharmacopeial method where no significant difference was observed between the proposed and reference methods.

주제어

참고문헌 (27)

1751 2009 Martindale - the complete drug reference
The British Pharmacopoeia. Her Majesty’s Stationary Office. London. 2010. pp. 1523-5, 2945.
The United States Pharmacopeia, 34th edition, The National Formulary, 29th ed., The Official Compendia of Standards, United States Pharmacopoeial Convention, Inc.: asian ed. Rockville, MD; 2011. pp. 779-82, 3675-6.
Wozniak vol. 19 397 1990
Pharmazie Koricanac 50 2 151 1995 Determination of nizatidine in pharmaceutical formulations by potentiometric titration

상세보기
J Pharm Biomed Anal El-Yazbi 31 5 1027 2003 10.1016/S0731-7085(02)00699-4 Spectrophotometric and titrimetric determination of nizatidine in capsules

상세보기
J Pharm Biomed Anal Al-Majed 21 2 319 1999 10.1016/S0731-7085(99)00129-6 The voltammetric behavior of nizatidine and its determination in biological fluids

상세보기
Mikrochim Acta Zuhri 134 3-4 153 2000 10.1007/s006040070031 Voltammetric and spectrophotometric determination of nizatidine in pharmaceutical formulations

상세보기
J AOAC Int Al-Ghannam 85 5 1003 2002 10.1093/jaoac/85.5.1003 Spectrophotometric determination of three antiulcer drugs through charge-transfer complexation

상세보기
J AOAC Int Walash 85 6 1316 2002 10.1093/jaoac/85.6.1316 Kinetic spectrophotometric method for the determination of ranitidine and nizatidine in pharmaceuticals

상세보기
J Pharm Biomed Anal Hassan 27 1-2 31 2002 10.1016/S0731-7085(01)00473-3 Kinetic spectrophotometric determination of nizatidine and ranitidine in pharmaceutical preparations

상세보기
Spectrochim Acta A Darwish 69A 1 33 2008 10.1016/j.saa.2007.03.005 Spectrophotometric determination of H2-receptor antagonists via their oxidation with cerium (IV)

상세보기
Analyst Chang 136 20 4168 2011 10.1039/c1an15078b Determination of ranitidine, nizatidine, and cimetidine by a sensitive fluorescent probe

상세보기
Electrophoresis Wu 22 13 2758 2001 10.1002/1522-2683(200108)22:13<2758::AID-ELPS2758>3.0.CO;2-P Simultaneous determination of cimetidine, famotidine, nizatidine, and ranitidine in tablets by capillary zone electrophoresis

상세보기
Anal Sci Nevado 27 4 427 2011 10.2116/analsci.27.427 Evaluation of non-aqueous capillary zone electrophoresis for the determination of histamine H2 receptor antagonists in pharmaceuticals

상세보기
Chromatographia Chung 59 Suppl. 1 S29 2004 10.1365/s10337-004-0213-0 Detection of anti-ulcer drugs and their metabolites in horse urine by liquid chromatography-mass spectrometry

상세보기
Drug Dev Ind Pharm Ho 25 3 379 1999 10.1081/DDC-100102186 Simultaneous high-performance liquid chromatographic analysis for famotidine, ranitidine-HCl, cimetidine, and nizatidine in commercial products

상세보기
Ther Drug Monit Yusuf 28 2 232 2006 10.1097/01.ftd.0000189902.08684.90 Validation of a new high-performance liquid chromatography assay for nizatidine

상세보기
J Chromatogr B Ashiru 860 2 235 2007 10.1016/j.jchromb.2007.10.029 Simple and universal HPLC-UV method to determine cimetidine, ranitidine, famotidine and nizatidine in urine: Application to the analysis of ranitidine and its metabolites in human volunteers

상세보기
J Chinese Pharm Sci Zhang 19 4 279 2010 10.5246/jcps.2010.04.039 Quantitative determination of nizatidine in human plasma and urine by high performance liquid chromatography and its pharmacokinetic study in humans
Bull Fac Pharm Cairo Univ El-Bardicy 33 2 1 1995 Sensitive spectrophotometric method for the determination of nizatidine in presence of its degradation products
Spectrosc Lett El-Gendy 34 2 221 2001 10.1081/SL-100002011 Stability indicating method for the determination of nizatidine using 3-methyl-2-benzothiazolinone hydrazone

상세보기
J AOAC Int Youssef 91 1 73 2008 10.1093/jaoac/91.1.73 Validated stability-indicating methods for the determination of nizatidine in the presence of its sulfoxide derivative

상세보기
Am J Anal Chem Gomes 2 3 314 2011 10.4236/ajac.2011.23039 Rapid validated stability indicating method for nizatidine and its impurities quantification

상세보기
Quim Nova Kumar 35 4 827 2012 10.1590/S0100-40422012000400032 Development and validation of a novel stability indicating RP-UPLC method for simultaneous determination of nizatidine, methylparaben and propylparaben in oral liquid pharmaceutical formulation

상세보기
J Chromatogr A Shabir 987 1-2 57 2003 10.1016/S0021-9673(02)01536-4

상세보기
ICH. Validation of Analytical Procedures: text and methodology, Q2(R1).In: International conference on harmonisation, November 2005.

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

HPLC-DAD stability indicating determination of nizatidine in bulk and capsules dosage form 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (27)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트